Edesa Biotech regains Nasdaq minimum bid price compliance; delisting risk removed

Edesa Biotech, Inc.

Received Nasdaq letter confirming compliance with minimum bid price of $1.00/share after 10 consecutive business days.
Previously received deficiency notice on June 22, 2023 with compliance deadline of December 19, 2023.
Common shares (EDSA) now meet Nasdaq Capital Market listing requirement; matter closed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.